Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis

Leukemia. 1998 Mar;12(3):441-2. doi: 10.1038/sj.leu.2400915.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Humans
  • Leukemia, Promyelocytic, Acute / chemically induced*
  • Male
  • Mitoxantrone / adverse effects*
  • Multiple Sclerosis / drug therapy*
  • Topoisomerase II Inhibitors

Substances

  • Topoisomerase II Inhibitors
  • Mitoxantrone